Abstract
In recent decades scientific research has demonstrated that the microbial world is infinitely richer and more surprising than we could have imagined. Every day, new molecules produced by microorganisms are discovered, and their incredible diversity has not yet delivered all of its messages. The current challenge of research is to select from the wide variety of characterized microorganisms and compounds, those which could provide rapid answers to crucial questions about human or animal health or more generally relating to society’s demands for medicine, pharmacology, nutrition or everyday well-being.
Highlights
Microorganisms and MetabolitesAn Incredible World of Novelty for Biotechnologists, New Opportunities for Industries
Laboratoire de Chimie et de Biotechnologie des Produits Naturels—CHEMBIOPRO, Université de la Réunion, 15 Avenue René Cassin, CS 92003, F-97744 Saint-Denis, Ile de la Réunion, France; Ecole Supérieure d’Ingénieurs Réunion Océan Indien—ESIROI Agroalimentaire, 2 Rue Joseph Wetzell, F-97490 Sainte-Clotilde, Ile de la Réunion, France
Great potential exists for the development of novel compounds for pharmaceutical, nutraceutical, dyeing, or agricultural industries. In this special issue secondary metabolites produced by bacteria, actinomycetes, fungi or microalgae are investigated under different facets linked with bioactivity or other interesting properties
Summary
An Incredible World of Novelty for Biotechnologists, New Opportunities for Industries. Great potential exists for the development of novel compounds for pharmaceutical, nutraceutical, dyeing, or agricultural industries In this special issue secondary metabolites produced by bacteria, actinomycetes, fungi or microalgae are investigated under different facets linked with bioactivity or other interesting properties. Theseofstrains are due to the panel of secondary metabolites they are able to produce These strains certainly one of the less explored sources of new active compounds. With the aim are of efficiently discovering new bioactive molecules, the diversification of the culture conditions of one strain may induce the activation of diverse biosynthetic gene clusters This OSMAC approach (one strain many compounds) is based on the fact that some microbial metabolites are not produced under certain set of physicochemical parameters and may appear when the conditions are modified. Thereafter, the construction of microbe consortia opens up an endless avenue of exploration towards the production of new bioactive molecules
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
